[Dialysis-associated hypertension].
Saruta
T
T
Department of Internal Medicine, School of Medicine, Keio University.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001798:Blood Proteins / Q000502:physiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002298:Cardenolides; D004077:Digoxin; D004232:Diuretics / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D011453:Prostaglandins / Q000378:metabolism / Q000502:physiology; D006435:Renal Dialysis / Q000009:adverse effects*; D012503:Saponins
D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D002121:Calcium Channel Blockers; D002298:Cardenolides; D004232:Diuretics; D011453:Prostaglandins; D012503:Saponins; C034504:digoxin-like factors; D004077:Digoxin